LABORATORIOS FARMAC. ROVI, S.A. secures contract for Direct Adjustment For Acquisition Of Risperidone [100 Mg/0490 Ml; Inj Lp Susp Powder; Syringe] And Risperidone [75 Mg/0383 Ml; Inj Lp Susp Powder; Syringe]

Portugal, Jan. 28 -- Portugal based LABORATORIOS FARMAC. ROVI, S.A. has secured contract from Unidade Local De Saude De Santa Maria, E. P. E. for Direct Adjustment For Acquisition Of Risperidone [100 Mg/0490 Ml; Inj Lp Susp Powder; Syringe] And Risperidone [75 Mg/0383 Ml; Inj Lp Susp Powder; Syringe]. The value of the contract is worth 2992891 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....